Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:14 pm Sale | 13G | AEVI GENOMIC MEDICINE INC GNMX | BAKER BROS. ADVISORS LP | 564,844 0.7% | -3,385,575 (-85.70%) | View |
| 2020-02-12 4:28 pm Sale | 13G | AEVI GENOMIC MEDICINE INC GNMX | ADAGE CAPITAL PARTNERS GP L.L.C. | 423,633 0.54% | -5,076,367 (-92.30%) | View |
| 2020-02-07 12:56 pm Purchase | 13D | AEVI GENOMIC MEDICINE INC GNMX | ASTRAZENECA PLC AZN | 12,946,900 16.7% | 12,946,900 (New Position) | View |
| 2020-01-06 4:06 pm Purchase | 13D | AEVI GENOMIC MEDICINE INC GNMX | Children's Hospital of Philadelphia Foundation | 57,280,927 49.1% | 6,473,450 (+12.74%) | View |
| 2019-12-06 5:18 pm Purchase | 13D | AEVI GENOMIC MEDICINE INC GNMX | Children's Hospital of Philadelphia Foundation | 50,807,477 52.3% | 4,661,074 (+10.10%) | View |
| 2019-11-20 4:30 pm Purchase | 13D | AEVI GENOMIC MEDICINE INC GNMX | Children's Hospital of Philadelphia Foundation | 46,146,403 47.5% | 24,834,817 (+116.53%) | View |
| 2019-10-22 4:59 pm Unchanged | 13D | AEVI GENOMIC MEDICINE INC GNMX | Children's Hospital of Philadelphia Foundation | 21,311,586 31.5% | 0 (Unchanged) | View |